<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[AstraZeneca Plc. | Company News & Executive Profiles - AZN | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/astrazeneca+plc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for AstraZeneca Plc.]]></description>
	<s:counts start="0" returned="10" found="776" />
	<language>en-us</language>
	<item>
		<title><![CDATA[AstraZeneca Moves Drug Production to China, Begging Safety Questions for FDA]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005527/astrazeneca-to-move-drug-production-to-china-trend-begs-safety-questions-for-fda/]]></link>
		<description><![CDATA[AstraZeneca AZN will move all its drug production to China. The move is part of a trend: Drug companies with massive Western operations are shutting them down and moving them to China. The unanswered question is, how will the FDA monitor production of drugs destined for the U.S. if all...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Fri, 27 Nov 2009 19:40:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/monitors+%2526+displays.html"><![CDATA[Monitors & Displays]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[FTSE Falls, Dubai Jitters Weigh]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-368470.html]]></link>
		<description><![CDATA[By Simon FalushLONDON (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - The top share index fell for a second session on Friday, as banks were pressured by persisting anxiety over Dubai's debt standstill while miners and energy stocks were weighed by falling commodity prices.By 9:26 a.m. the FTSE 100  was down 0.3 percent or...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_reutersUK.gif" type="image/gif" />
		<pubDate>Fri, 27 Nov 2009 02:00:21 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bank.html"><![CDATA[Bank]]></category>
		<category domain="http://resources.bnet.com/topic/dubai.html"><![CDATA[Dubai]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/ftse.html"><![CDATA[FTSE]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/royal+dutch+shell+plc..html"><![CDATA[Royal Dutch Shell Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/standard+parking+corp..html"><![CDATA[Standard Parking Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RDSA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">STAN</category>
		<category domain="tickers">AZN,GSK,RDSA,STAN</category>
	</item>
	<item>
		<title><![CDATA[FTSE Seen Opening 35-46 Points Lower]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-368463.html]]></link>
		<description><![CDATA[LONDON (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - FTSE 100  is seen opening 35-46 points lower on Friday according to financial bookmakers, extending losses from the previous session following weakness in Asia as worries about the global economy mounted after Dubai's debt problems emerged.The index is seen opening down as much as 0.9...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_reutersUK.gif" type="image/gif" />
		<pubDate>Thu, 26 Nov 2009 23:15:18 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/dubai.html"><![CDATA[Dubai]]></category>
		<category domain="http://resources.bnet.com/topic/ftse+100.html"><![CDATA[FTSE 100]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/ftse.html"><![CDATA[FTSE]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/royal+dutch+shell+plc..html"><![CDATA[Royal Dutch Shell Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RDSA</category>
		<category domain="tickers">AZN,RDSA</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca files Brilinta NDA]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/astrazeneca-files-brilinta-nda/21115/]]></link>
		<description><![CDATA[ AstraZeneca today announced it has submitted an NDA to the FDA for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome ACS. The proposed trade name for ticagrelor is Brilinta, pending approval from the FDA.  Release  ]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 19 Nov 2009 09:03:51 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/reduction.html"><![CDATA[reduction]]></category>
		<category domain="http://resources.bnet.com/topic/treatment.html"><![CDATA[treatment]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Judge: Send federal Seroquel suits to courts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/judge-send-federal-seroquel-suits/21113/]]></link>
		<description><![CDATA[While AstraZeneca preps for its first Seroquel liability trials at the state level, federal lawsuits are coming closer to court as well. U.S. District Judge Anne Conway, who's overseeing pretrial work for thousands of federal Seroquel cases, said she will ask a panel of judges to send all those cases...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 19 Nov 2009 09:03:01 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bloomberg+l.p..html"><![CDATA[Bloomberg L.P.]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[FTSE Hits 14-month Closing High]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-365181.html]]></link>
		<description><![CDATA[By Tricia WrightLONDON (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - The FTSE 100  hit its highest closing level in more than 14 months on Monday as a weaker dollar sparked a rally in metals prices and some upbeat U.S. data lifted market sentiment.The top share index ended up 86.29 points, or 1.6 percent,...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_reutersUK.gif" type="image/gif" />
		<pubDate>Mon, 16 Nov 2009 10:00:31 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bp+plc.html"><![CDATA[BP Plc]]></category>
		<category domain="http://resources.bnet.com/topic/ftse.html"><![CDATA[FTSE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[Financial]]></category>
		<category domain="http://resources.bnet.com/topic/royal+dutch+shell+plc..html"><![CDATA[Royal Dutch Shell Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/standard+parking+corp..html"><![CDATA[Standard Parking Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RDSA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">STAN</category>
		<category domain="tickers">AZN,RDSA,STAN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca, A Psychiatrist And Big Seroquel Bucks]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/astrazeneca-psychiatrist-seroquel-bucks/19912/]]></link>
		<description><![CDATA[In 2001, AstraZeneca execs faced a high-stakes dilemma - psychiatrist Michael Reinstein was bringing in a small fortune in sales and conducting research that made one of its most promising drugs look spectacular, The Chicago Tribune writes. But some worried his research might be too good to be true. As...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Wed, 11 Nov 2009 06:31:12 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca's New Blog Is Slammed by Critics]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005180/astrazenecas-new-blog-is-slammed-by-critics/]]></link>
		<description><![CDATA[AstraZeneca AZN has launched a blog -- AZ Health Connections -- and the critics don't like it. There have only been five posts on it since Oct. 16, but already PharmExec has declared that the blog "falls flat" and Pharma Marketer says the posts "leave little upon which to engage."...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Fri, 06 Nov 2009 11:13:42 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[Blog]]></category>
		<category domain="http://resources.bnet.com/topic/blogging.html"><![CDATA[Blogging]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[Internet]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[J&J Slashing Workforce]]></title>
		<link><![CDATA[http://www.bnet.com/2407-14055_23-360154.html]]></link>
		<description><![CDATA[By Ransdell PiersonNEW YORK (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - Johnson & Johnson JNJ plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday.J&J said the planned restructuring...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_reutersUK.gif" type="image/gif" />
		<pubDate>Tue, 03 Nov 2009 11:45:46 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/workforce.html"><![CDATA[Workforce]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/elan+corp.+plc..html"><![CDATA[Elan Corp. Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">AZN,BMY,GSK,JNJ,MRK,PFE</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca to Pay $520 Million to Settle Four Seroquel Cases - NYT]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/astrazeneca-pay-520-million-settle/18364/]]></link>
		<description><![CDATA[    The pharmaceutical company  AstraZeneca  said Thursday that it had reached a $520 million agreement to settle two federal investigations and two whistle-blower lawsuits over the sale and marketing of its blockbuster psychiatric drug Seroquel.    One of the investigations related to "selected...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Fri, 30 Oct 2009 14:00:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
</channel>
</rss>
